Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Unique study evaluates Irish pharmacy education

By R&D Editors | February 2, 2011

Unique study evaluates Irish pharmacy education

A research team from Aston University in Birmingham, UK has completed The Pharmacy Education and Accreditation Reviews Project (PEARS), which reviewed professional pharmacy education as a whole in Ireland. The Project was led by Professor Keith Wilson and Dr Chris Langley, who are based in the School of Life & Health Sciences at Aston.

The report has been approved without modification by the Council of the Pharmaceutical Society of Ireland and has also received endorsement from Irish politician Mary Harney, who is currently Minister for Health and Children.

 An implementation group has now been set up by the Pharmaceutical Society of Ireland (PSI), which will implement the recommendations in the Aston report by the 2012/2013 academic year.

The Aston team were also responsible for the biggest UK study examining pharmacy education which took place in 2005. This looked at the four year MPharm programme across the UK, and the results of this study are currently informing a review of pharmacy education in the UK.

Dr Chris Langley explained: ‘In the PEARS Project, we assessed the strengths and weaknesses of the current system of pharmacy education in Ireland, gathered the views of key stakeholders and also made recommendations for the best ways to take undergraduate pharmacy education and training forward in Ireland. We made six major recommendations, with the most important being that the current ‘4 + 1’ model (where students spend four years at university and one year pre-registration) be replaced with a five year, fully integrated programme.’

Professor Paul Gallagher, who is Head of Pharmacy at The Royal College of Surgeons in Ireland (RCSI) and Chair of the Professional Development and Learning Committee of the PSI, said: ‘The importance of this report cannot be over-stated. It was most important that an evidence based approach was adopted to the structure of pharmacy education going forward in the Republic of Ireland.

‘This report will enable policy and decision makers within the Irish Government to place pharmacy education at a point where it can be placed amongst the highest internationally benchmarked systems. Improvements in the education and training of pharmacists will also allow for significant enhancement to be made to the delivery of pharmacy services in Ireland as we move to expand the scope of clinical services that pharmacists will lead on though their participation in integrated care pathways.

‘It must be with a great sense of pride that the Aston team realise that they have chartered the course of pharmacy education in an entire jurisdiction for decades to come.’

SOURCE

Related Articles Read More >

Why IBM predicts quantum advantage within two years
Aardvark AI forecasts rival supercomputer simulations while using over 99.9% less compute
This week in AI research: Latest Insilico Medicine drug enters the clinic, a $0.55/M token model R1 rivals OpenAI’s $60 flagship, and more
How the startup ALAFIA Supercomputers is deploying on-prem AI for medical research and clinical care
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE